Additional Information

Description

Trivisc Sodium Hyaluronate 25 mg in a 2.5 mL prefilled syringe is an injectable product used in the management of osteoarthritis, particularly for providing relief in joint pain and improving mobility. The preparation contains a high concentration of sodium hyaluronate. It acts as a lubricant, reducing friction and improving joint function by restoring the viscosity of synovial fluid in patients with degenerative joint diseases.

The product is administered via intra-articular injection, typically following a 3-injection regimen. Each injection provides a 25 mg dose of sodium hyaluronate in a volume of 2.5 mL, allowing for effective delivery directly to the affected joint. The 3-injection protocol is designed to provide sustained relief from joint pain and improve joint mobility over an extended period.

The sodium hyaluronate in Trivisc works by providing lubrication and shock absorption to the affected joint, alleviating symptoms of osteoarthritis such as pain, swelling, and stiffness. It also has the potential to reduce inflammation, further contributing to pain relief and functional improvement.